tiprankstipranks
Trending News
More News >
Precipio Inc (PRPO)
NASDAQ:PRPO
US Market
Advertisement

Precipio (PRPO) Earnings Dates, Call Summary & Reports

Compare
439 Followers

Earnings Data

Report Date
Nov 24, 2025
TBA (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
Last Year’s EPS
-0.42
Same Quarter Last Year
Based on 1 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 13, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call for Precipio shows strong financial and operational improvements, particularly in revenue growth and gross margin enhancement. While there were minor setbacks, such as a slight decline in product gross margin and operational challenges faced by the Products division, the company has demonstrated resilience and strategic foresight to overcome these issues. The overall sentiment is positive, with significant progress towards breakeven and strategic initiatives in place to support continued growth.
Company Guidance
During the Precipio Q2 2025 Shareholder Update Conference Call, CEO Ilan Danieli highlighted strong performance metrics, including a 70% annualized growth rate in the Pathology Services division and a 23% quarter-over-quarter revenue increase in the Products division, almost doubling on an annualized basis. Gross margins improved from 39% to 43%, despite a temporary decline in product gross margin. Danieli emphasized a robust pipeline for Q3 with new customers in onboarding stages, contributing to continued growth. The company reached a new record in July, exceeding $2 million in monthly Pathology Services revenue. Strategic investments were made in lab space and equipment, with management confident of reaching breakeven in 2025 without additional capital. The call also detailed a warrant conversion strategy to minimize dilution and highlighted increased interest from investors, contributing to a significant stock price increase.
Strong Revenue Growth in Pathology Services
The Pathology Services division is growing at an annualized growth rate of about 70%, contributing positively to overall company performance.
Products Division Recovery
Products revenue grew by 23% from the previous quarter, representing an almost 100% annualized growth rate, indicating recovery from last year's temporary decline.
Gross Margin Improvement
Overall company gross margins improved from 39% to 43%, showing positive financial progress.
New Customer Pipeline
A strong pipeline of new customers is in various onboarding stages, expected to contribute to continued growth in Q3.
Record Revenue in July
In July, Pathology Services achieved a new record, exceeding $2 million in revenue in a single month.
Strategic Investment in Laboratory Expansion
Investments were made in expanding laboratory space and acquiring key equipment, with only a modest impact on near-term trajectory towards breakeven.
Distributor Pipeline Growth
An increase in the pipeline generated by distributors marks progress in scaling up the business.
Warrant Conversion Structure to Minimize Dilution
The company structured a warrant conversion to minimize dilution and manage capital structure responsibly.

Precipio (PRPO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

PRPO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 24, 2025
2025 (Q3)
- / -
-0.42
Aug 13, 2025
2025 (Q2)
- / 0.05
-0.83105.54% (+0.88)
May 14, 2025
2025 (Q1)
- / -
-1.458
Mar 31, 2025
2024 (Q4)
- / -0.24
0.651-137.48% (-0.90)
Nov 18, 2024
2024 (Q3)
- / -0.42
-1.0459.62% (+0.62)
Aug 19, 2024
2024 (Q2)
- / -0.83
-1.8855.85% (+1.05)
May 15, 2024
2023 (Q4)
- / -1.46
-2.643.92% (+1.14)
Nov 20, 2023
2023 (Q3)
-1.21 / -1.04
-2.862.86% (+1.76)
Aug 01, 2023
2023 (Q2)
-2.00 / -1.88
-1.8880.42% (<+0.01)
May 17, 2023
2023 (Q1)
- / -
-0.2
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

PRPO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 13, 2025
$14.29$14.71+2.94%
May 14, 2025
$6.93$7.15+3.17%
Mar 31, 2025
$6.27$5.65-9.89%
Nov 18, 2024
$6.19$6.08-1.78%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Precipio Inc (PRPO) report earnings?
Precipio Inc (PRPO) is schdueled to report earning on Nov 24, 2025, TBA (Confirmed).
    What is Precipio Inc (PRPO) earnings time?
    Precipio Inc (PRPO) earnings time is at Nov 24, 2025, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is PRPO EPS forecast?
          Currently, no data Available
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis